<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2008-12-1-58-63</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1015</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. EXPERIMENTAL INVESTIGATION</subject></subj-group></article-categories><title-group><article-title>О  РОЛИ  ПРОЦЕСОВ  СВОБОДНО-РАДИКАЛЬНОГО  ОКИСЛЕНИЯ  В  РАЗВИТИИ  ЭКСПЕРИМЕНТАЛЬНОГО  НЕФРОЛИТИАЗА</article-title><trans-title-group xml:lang="en"><trans-title>ON THE  ROLE  OF  PROCESSES OF  FREE  RADICAL OXIDATION  IN THE  DEVELOPMENT OF  EXPERIMENTAL  NEPHROLITHIASIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зверев</surname><given-names>Я. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Zverev</surname><given-names>Ya. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры фармакологии и гистологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брюханов</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bryukhanov</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры фармакологии и гистологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Талалаева</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Talalaeva</surname><given-names>O. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры фармакологии и гистологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лампатов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lampatov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры фармакологии и гистологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жариков</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Zharikov</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры фармакологии и гистологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Талалаев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Talalaev</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры фармакологии и гистологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Булгакова</surname><given-names>Я. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulgakova</surname><given-names>Ya. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры фармакологии и гистологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Алтайский государственный медицинский университет</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>10</day><month>01</month><year>2008</year></pub-date><volume>12</volume><issue>1</issue><fpage>58</fpage><lpage>63</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зверев Я.Ф., Брюханов В.М., Талалаева О.С., Лампатов В.В., Жариков А.Ю., Талалаев С.В., Булгакова Я.С., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Зверев Я.Ф., Брюханов В.М., Талалаева О.С., Лампатов В.В., Жариков А.Ю., Талалаев С.В., Булгакова Я.С.</copyright-holder><copyright-holder xml:lang="en">Zverev Y.F., Bryukhanov V.M., Talalaeva O.S., Lampatov V.V., Zharikov A.Y., Talalaev S.V., Bulgakova Y.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1015">https://journal.nephrolog.ru/jour/article/view/1015</self-uri><abstract><p>ЦЕЛЬЮ ИССЛЕДОВАНИЯ явилось изучение процесса свободно-радикального окисления в почках и крови крыс с экспериментальной мочекаменной болезнью. МАТЕРИАЛ И МЕТОДЫ. Эксперименты проведены на самцах крыс Wistar, получавших в виде питья на протяжении 21 дня 1%-й раствор этиленгликоля. Гистохимически в почечных срезах определяли наличие кристаллов оксалата кальция. Биохимическими методами оценивали оксидантный (тиобарбитуратреактивные продукты, общая оксидантная активность) и антиоксидантный (каталаза, супероксиддисмутаза, глутатионпероксидаза, общая антиоксидантная активность) статусы почек и крови. РЕЗУЛЬТАТЫ. В ходе экспериментов в срезах почек всех крыс, потреблявших этиленгликоль, зафиксировали значительное количество Са-позитивных кристаллов, локализованных преимущественно на поверхности почечного сосочка. Развитие нефролитиаза сопровождалось мощной активацией свободно-радикального окисления как в почках, так и в крови животных. Одновременно выявлялось ослабление антиоксидантной защиты, обусловленное в основном угнетением активности глутатионпероксидазы. ЗАКЛЮЧЕНИЕ. Таким образом, в условиях экспериментального оксалатного нефролитиаза у крыс происходит активация свободно-радикального окисления в почках и крови животных. Этот процесс сопровождается ослаблением активности глутатионпероксидазы, одного из основных антиоксидантных ферментов.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM of the investigation was to study the process of free-radical oxidation in the kidneys and blood of rats with experimental urolithiasis. MATERIAL AND METHODS. Experiments were carried out in male Wistar rats given 1% solution of ethylene glycol in drinking water during 21 days. The presence of calcium oxalate crystals in kidney slices was determined histochemically Biochemical methods were used to assess the oxidant (thiobarbiturate reactive products, total oxidant activity) and antioxidant (catalase, superoxiddismutase, glutathione peroxidase, total antioxidant activity) status of the kidneys and blood. RESULTS. Considerable number of Ca-positive crystals localized mainly on the surface of the renal papilla was determined in kidney slices of all rats receiving ethylene glycol. Progression of nephrolithiasis was accompanied by intense activation of free-radical oxidation both in the kidneys and in blood. Abatement of antioxidant defense was simultaneously observed due to the inhibition of activity of glutathione peroxidase. CONCLUSION. Thus, activation of free-radical oxidation in the kidneys and  blood of animals takes place under conditions of experimental oxalate nephrolithiasis in rats. This process is followed by weakened activity of glutathione peroxidase as one of the main antioxidant enzymes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>экспериментальный нефролитиаз</kwd><kwd>свободно-радикальное окисление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>experimental nephrolithiasis</kwd><kwd>free-radical oxidation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Тиктинский ОЛ, Александров ВП. Мочекаменная болезнь. Питер, СПб., 2000; 3-12</mixed-citation><mixed-citation xml:lang="en">Тиктинский ОЛ, Александров ВП. Мочекаменная болезнь. Питер, СПб., 2000; 3-12</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115 (10): 2598-2608</mixed-citation><mixed-citation xml:lang="en">Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115 (10): 2598-2608</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris) 2005; 39 (6): 209-231</mixed-citation><mixed-citation xml:lang="en">Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris) 2005; 39 (6): 209-231</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol 2007; 177: 31-38</mixed-citation><mixed-citation xml:lang="en">Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol 2007; 177: 31-38</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Кадыров ЗА, Истратов ВГ, Сулейманов СИ. Некоторые вопросы этиологии и патогенеза мочекаменной болезни. Урология 2006; 5: 98-101</mixed-citation><mixed-citation xml:lang="en">Кадыров ЗА, Истратов ВГ, Сулейманов СИ. Некоторые вопросы этиологии и патогенеза мочекаменной болезни. Урология 2006; 5: 98-101</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Thamilselvan S, Selvan R. Effect of vitamin E and mannitol on renal calcium oxalate retention in experimental nephrolithiasis. Indian J Biochem Biophys 1997; 34 (3): 319-323</mixed-citation><mixed-citation xml:lang="en">Thamilselvan S, Selvan R. Effect of vitamin E and mannitol on renal calcium oxalate retention in experimental nephrolithiasis. Indian J Biochem Biophys 1997; 34 (3): 319-323</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Thamilselvan S, Hackett RL, Khan SR. Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 1999; 10 [Suppl 14]: S452-S456</mixed-citation><mixed-citation xml:lang="en">Thamilselvan S, Hackett RL, Khan SR. Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 1999; 10 [Suppl 14]: S452-S456</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Thamilselvan S, Khan SR, Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 2003; 31 (1): 3-9</mixed-citation><mixed-citation xml:lang="en">Thamilselvan S, Khan SR, Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 2003; 31 (1): 3-9</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Huang HS, Chen CF, Chien CT, Chen J. Possible biphasic changes of free radicals in ethylene glycol-induced nephrolithiasis in rats. BJU Int 2000; 85 (9): 1143-1149</mixed-citation><mixed-citation xml:lang="en">Huang HS, Chen CF, Chien CT, Chen J. Possible biphasic changes of free radicals in ethylene glycol-induced nephrolithiasis in rats. BJU Int 2000; 85 (9): 1143-1149</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Huang HS, Ma MC, Chen J, Chen CF. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals. Neuronal Urodyn 2003; 22 (2): 176-182</mixed-citation><mixed-citation xml:lang="en">Huang HS, Ma MC, Chen J, Chen CF. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals. Neuronal Urodyn 2003; 22 (2): 176-182</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Huang HS, Ma MC, Chen CF, Chen J. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 2003; 62 (6): 1123-1128</mixed-citation><mixed-citation xml:lang="en">Huang HS, Ma MC, Chen CF, Chen J. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 2003; 62 (6): 1123-1128</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Aihara K, Byer KJ, Khan SR. Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 2003; 64 (4): 1283-1291</mixed-citation><mixed-citation xml:lang="en">Aihara K, Byer KJ, Khan SR. Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 2003; 64 (4): 1283-1291</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sumitra K, Pragasam V, Sakthivel R et al. Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 2005; 20 (7): 1407-1415</mixed-citation><mixed-citation xml:lang="en">Sumitra K, Pragasam V, Sakthivel R et al. Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 2005; 20 (7): 1407-1415</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tungsanga K, Sriboonlue P, Futrakul P et al. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 2005; 33 (1): 65-69</mixed-citation><mixed-citation xml:lang="en">Tungsanga K, Sriboonlue P, Futrakul P et al. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 2005; 33 (1): 65-69</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Khan SR, Hackett RL. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Scan Electron Microsc 1985; Pt 2: 759-774</mixed-citation><mixed-citation xml:lang="en">Khan SR, Hackett RL. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Scan Electron Microsc 1985; Pt 2: 759-774</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">de Water R, Boeve ER, van Miert PP et al. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. Scanning Microsc 1996; 10 (2): 591-601</mixed-citation><mixed-citation xml:lang="en">de Water R, Boeve ER, van Miert PP et al. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. Scanning Microsc 1996; 10 (2): 591-601</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Khan SR. Animal models of kidney stone formation: an analysis. World J Urol 1997; 15(4): 236-243</mixed-citation><mixed-citation xml:lang="en">Khan SR. Animal models of kidney stone formation: an analysis. World J Urol 1997; 15(4): 236-243</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Green ML, Hatch M, Freel RW. Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 2005; 289: F536-F543</mixed-citation><mixed-citation xml:lang="en">Green ML, Hatch M, Freel RW. Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 2005; 289: F536-F543</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaguchi S, Wiessner JH, Hasegawa AT et al. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 2005; 12 (3): 290-298</mixed-citation><mixed-citation xml:lang="en">Yamaguchi S, Wiessner JH, Hasegawa AT et al. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 2005; 12 (3): 290-298</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar S, Sigmon D, Miller T et al. A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 1991; 146 (5): 1384-1389</mixed-citation><mixed-citation xml:lang="en">Kumar S, Sigmon D, Miller T et al. A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 1991; 146 (5): 1384-1389</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">de Bruijn WC, Boeve ER, van Run PR et al. Etiology of calcium oxalate nephrolithasis in rats. II. The role of the papilla in stone formation. Scanning Microsc 1995; 9 (1): 115-124</mixed-citation><mixed-citation xml:lang="en">de Bruijn WC, Boeve ER, van Run PR et al. Etiology of calcium oxalate nephrolithasis in rats. II. The role of the papilla in stone formation. Scanning Microsc 1995; 9 (1): 115-124</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Khan SR. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. Scanning Microsc 1995; 9 (1): 89-100</mixed-citation><mixed-citation xml:lang="en">Khan SR. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. Scanning Microsc 1995; 9 (1): 89-100</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003; 111(5): 602-605</mixed-citation><mixed-citation xml:lang="en">Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003; 111(5): 602-605</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Рытикова ОС, Брюханов ВМ, Зверев ЯФ, Госсен ИЕ. Роль перекисного окисления липидов в патогенезе непродолжительной ишемии почки в эксперименте. Нефрология 2004; 8 (4): 115-116</mixed-citation><mixed-citation xml:lang="en">Рытикова ОС, Брюханов ВМ, Зверев ЯФ, Госсен ИЕ. Роль перекисного окисления липидов в патогенезе непродолжительной ишемии почки в эксперименте. Нефрология 2004; 8 (4): 115-116</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Muthukumar A, Selvan R. Renal injury mediated calcium oxalate nephrolithiasis: role of lipid peroxidation. Ren Fail 1997; 19 (3): 401-408</mixed-citation><mixed-citation xml:lang="en">Muthukumar A, Selvan R. Renal injury mediated calcium oxalate nephrolithiasis: role of lipid peroxidation. Ren Fail 1997; 19 (3): 401-408</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Huang HS, Ma MC, Chen J, Chen CF. Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol 2002; 167 (6): 2584-2593</mixed-citation><mixed-citation xml:lang="en">Huang HS, Ma MC, Chen J, Chen CF. Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol 2002; 167 (6): 2584-2593</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Selvan R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 2002; 30 (1): 35-47</mixed-citation><mixed-citation xml:lang="en">Selvan R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 2002; 30 (1): 35-47</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Khan SR. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 2004; 98 (2): e55-e60</mixed-citation><mixed-citation xml:lang="en">Khan SR. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 2004; 98 (2): e55-e60</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 2005; 33 (5): 349-357</mixed-citation><mixed-citation xml:lang="en">Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 2005; 33 (5): 349-357</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Rashed T, Menon M, Thamilselvan S. Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 2004; 24 (5): 557-568</mixed-citation><mixed-citation xml:lang="en">Rashed T, Menon M, Thamilselvan S. Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 2004; 24 (5): 557-568</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Huang HS, Chen J, Chen CF, Ma MC. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 2006; 70 (4): 699-710</mixed-citation><mixed-citation xml:lang="en">Huang HS, Chen J, Chen CF, Ma MC. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 2006; 70 (4): 699-710</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Veena CK, Josephine A, Preetha SP et al. Renal peroxidative changes mediated by oxalate: the protective role of fucaidan. Life Sci 2006; 79 (19): 1789-1795</mixed-citation><mixed-citation xml:lang="en">Veena CK, Josephine A, Preetha SP et al. Renal peroxidative changes mediated by oxalate: the protective role of fucaidan. Life Sci 2006; 79 (19): 1789-1795</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Thamilsulvan S, Menon M. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 2005; 96 (1): 117-126</mixed-citation><mixed-citation xml:lang="en">Thamilsulvan S, Menon M. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 2005; 96 (1): 117-126</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Meimaridou E, Lobos E, Hothersall JS. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis. Am J Physiol Renal Physiol 2006; 291: F731-F740</mixed-citation><mixed-citation xml:lang="en">Meimaridou E, Lobos E, Hothersall JS. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis. Am J Physiol Renal Physiol 2006; 291: F731-F740</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
